SCHEMBL7305124

SCHEMBL7305124

CCN(CC)C(=O)c1cc(F)c(C)c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
HSP90AA1 P07900 4/20 0.40
HSP90AB1 P08238 4/20 0.40
LMNA P02545 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TSHR P16473 2/20 0.37
COMT P21964 1/20 0.37
MLYCD O95822 1/20 0.37
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
RECQL P46063 1/20 0.36
KEAP1 Q14145 1/20 0.36
ALPL P05186 1/20 0.35
F10 P00742 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7294976 0.86 HPGD (0.40) HPGDTDP1HSP90AA1HSP90AB1LMNA
SCHEMBL7421174 0.86 HPGD (0.40) HPGDTDP1HSP90AA1HSP90AB1LMNA
SCHEMBL13991796 0.76 KDM4E (0.41) HPGDHSP90AA1HSP90AB1LMNAMEN1
SCHEMBL2334415 0.74 HPGD (0.46) HPGDTDP1HSP90AA1HSP90AB1LMNA
SCHEMBL1020497 0.74 ALDH1A1 (0.43) TDP1SMN1; SMN2TSHRPOLBKEAP1
SCHEMBL3599082 0.74 KEAP1 (0.42) TDP1MEN1KMT2AKDM4EKEAP1
SCHEMBL11358159 0.74 TSHR (0.42) KMT2ASMN1; SMN2TSHRKDM4EMAPK1
SCHEMBL12677875 0.72 HPGD (0.51) HPGDTDP1HSP90AA1HSP90AB1LMNA
SCHEMBL31330707 0.72 ERN1 (0.42) HPGDTDP1HSP90AA1HSP90AB1LMNA
SCHEMBL471668 0.72 HPGD (0.51) HPGDTDP1HSP90AA1HSP90AB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550111-B1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them SANOFI SA (FR) 1999-04-14 EP disclosed
US-5856349-A 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof SANOFI (FR) 1999-01-05 US disclosed
US-5783589-A 2-saccharinylmethyl aryl and arloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof SANOFI (FR) 1998-07-21 US disclosed
US-5652254-A TREATMENT OF DEGENERATIVE DISEASES, RHEUMATOID ARTHRITIS, PSORIASIS, CYSTIC FIBROSIS SANOFI, S.A. (FR) 1997-07-29 US disclosed
US-5597841-A 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP, INC. (US) 1997-01-28 US disclosed
US-5563163-A TREATMENT OF DEGENERATIVE DISEASES STERLING WINTHROP, INC. (US) 1996-10-08 US disclosed
US-5512589-A TREATING DEGENERATIVE DISEASES STERLING WINTHROP INC. (US) 1996-04-30 US disclosed
US-5489604-A TREATING DEGENERATIVE DISEASES STERLING WINTHROP, INC. (US) 1996-02-06 US disclosed
US-5488062-A 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1996-01-30 US disclosed
US-5385923-A Treatment of degenerative diseases STERLING WINTHROP INC. (US) 1995-01-31 US disclosed
US-5376653-A A protease enzyme inhibitor for treating degenerative diseases , respiratory system disorders, rheumatoid arthritis and pancreatitis STERLING WINTHROP INC. (US) 1994-12-27 US disclosed
US-5306818-A Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis STERLING WINTHROP INC. (US) 1994-04-26 US disclosed
EP-0550111-A1 2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them STERLING WINTHROP INC. (US) 1993-07-07 EP disclosed
EP-0550112-A1 2-Saccharinylmethyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and pharmaceutical compositions contaning them STERLING WINTHROP INC. (US) 1993-07-07 EP disclosed
US-5128339-A Emphysema, rheumatoid arthritis, pancreatitis STERLING WINTHROP INC. (US) 1992-07-07 US disclosed
EP-0483928-A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use STERLING WINTHROP INC. (US) 1992-05-06 EP disclosed